Longevity and Healthspan Science vs. Tech Bro Biohacking
The longevity industry is currently a “Wild West” of untested claims, overwhelming data, and ever-contested markets. While U.S. lifespan is slowly rebounding post-COVID, healthspan continues to lag due to chronic disease and environmental stressors. To truly advance salutogenesis and catch disease upstream, the ecosystem must move beyond noise and adopt the rigorous N-of-1 data collection models also required for personalized oncology. Amidst the biohacking hyperbole and the medicalization of aging,